364 related articles for article (PubMed ID: 28119020)
1. In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes.
Smith JN; Mehinagic D; Nag S; Crowell SR; Corley RA
Toxicol Lett; 2017 Mar; 269():23-32. PubMed ID: 28119020
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes.
Crowell SR; Hanson-Drury S; Williams DE; Corley RA
Toxicol Lett; 2014 Jul; 228(1):48-55. PubMed ID: 24769260
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
4. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
[TBL] [Abstract][Full Text] [Related]
5. Competitive Metabolism of Polycyclic Aromatic Hydrocarbons (PAHs): An Assessment Using In Vitro Metabolism and Physiologically Based Pharmacokinetic (PBPK) Modeling.
Smith JN; Gaither KA; Pande P
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886113
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of chrysene by brown bullhead liver microsomes.
Pangrekar J; Kole PL; Honey SA; Kumar S; Sikka HC
Toxicol Sci; 2003 Jan; 71(1):67-73. PubMed ID: 12520076
[TBL] [Abstract][Full Text] [Related]
7. Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.
Pande P; Madeen EP; Williams DE; Crowell SR; Ognibene TJ; Turteltaub KW; Corley RA; Smith JN
Toxicol Appl Pharmacol; 2022 Mar; 438():115830. PubMed ID: 34933053
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
9. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol.
Shou M; Korzekwa KR; Crespi CL; Gonzalez FJ; Gelboin HV
Mol Carcinog; 1994 Jul; 10(3):159-68. PubMed ID: 8043197
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
Luch A; Platt KL; Seidel A
Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
[TBL] [Abstract][Full Text] [Related]
11. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the genotoxicity of dibenzo[c,p]chrysene in human carcinoma MCF-7 cells in culture.
Mahadevan B; Luch A; Atkin J; Nguyen T; Sharma AK; Amin S; Baird WM
Chem Biol Interact; 2006 Dec; 164(3):181-91. PubMed ID: 17094953
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene.
Yuan ZX; Sikka HC; Munir S; Kumar A; Muruganandam AV; Kumar S
Chem Res Toxicol; 2003 Dec; 16(12):1581-8. PubMed ID: 14680372
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases.
Olson KC; Sun D; Chen G; Sharma AK; Amin S; Ropson IJ; Spratt TE; Lazarus P
Chem Res Toxicol; 2011 Sep; 24(9):1549-59. PubMed ID: 21780761
[TBL] [Abstract][Full Text] [Related]
15. Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.
Crowell SR; Amin SG; Anderson KA; Krishnegowda G; Sharma AK; Soelberg JJ; Williams DE; Corley RA
Toxicol Appl Pharmacol; 2011 Dec; 257(3):365-76. PubMed ID: 22001385
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
Amin S; Desai D; Dai W; Harvey RG; Hecht SS
Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
[TBL] [Abstract][Full Text] [Related]
20. Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast.
Gautier JC; Lecoeur S; Cosme J; Perret A; Urban P; Beaune P; Pompon D
Pharmacogenetics; 1996 Dec; 6(6):489-99. PubMed ID: 9014198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
